Oral COVID-19 vaccines
VACINO-CO is designed to protect against most COVID-19 viruses and related variants.
Source: LinkedIn company description · Retrieved October 13, 2026
Founded in 2020, Vacino Biotech develops nucleic acid drugs and universal vaccines.
The company has invested in developing COVID-19 T-cell vaccine products using its SED vaccine design technology. The company has invested in nucleic acid drug development for Alzheimer's disease and brain delivery technology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
VACINO-CO is designed to protect against most COVID-19 viruses and related variants.
Source: LinkedIn company description · Retrieved October 13, 2026
Vacino-ADmir is a microRNA drug described as inhibiting neuroinflammation through the PD1/PDL1 mechanism.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.